Kellton Delays FCCB as Rights Issue Awaits Exchange Approval
Key highlights
- Kellton reported H1 FY'27 revenue of Rs 637 crore, up 6.6% from Rs 597 crore a year earlier.
- Kellton said it has no current plan to execute the FCCB at the prevailing share price.
- Kellton's rights issue was awaiting NSE and BSE approval as of November 16, 2026.
- Kellton reported six Q2 FY'27 client wins across finance, healthcare, aviation, logistics, agriculture and hearing-aid engineering.
powered by IRIS

Kellton Tech Solutions Limited deferred its proposed foreign currency convertible bond, or FCCB, in Q2 FY'27 because management said the current share price does not support dilution, while its rights issue remained pending with exchanges after H1 FY'27 revenue rose 6.6% year on year to Rs 637 crore.
Know Kellton Tech Solutions inside out
Results, valuation, peers and who's buying, in one view.
Why did Kellton delay the FCCB?
Kellton delayed the FCCB because management said it would not dilute equity at the current share price. On the November 16, 2026 earnings call, Chairman Niranjan Chintam cited global and macroeconomic conditions, the Iran-Iraq war, US election developments and pressure on information-technology sector valuations as factors affecting the share price.
Management said the FCCB would be considered when market and financial conditions improve, rather than on an immediate timetable. Chintam said management believed the share price did not reflect Kellton's value, but this was management's opinion and not a disclosed valuation target. The call gave no conversion price, coupon, maturity, currency, issue date or final dilution estimate for the FCCB.
Kellton described the approved FCCB authority as an enabling resolution that had received board and shareholder approval. Management said there were no current plans to execute the FCCB, distinguishing the approval from a completed or scheduled capital raise. That leaves both the fundraising date and the final terms unresolved as of the Q2 FY'27 call.
How would Kellton use eventual FCCB proceeds?
Kellton said eventual FCCB proceeds would be used to retire debt, pursue targeted acquisitions and invest in intellectual property, or IP. Management did not identify the debt amount to be repaid, name acquisition targets or allocate a specific portion of the proposed funds among debt reduction, acquisitions and IP.
The IP investment plan includes artificial intelligence-related frameworks and products, including Phoenix AI, according to management. Chintam said a framework or platform can allow faster delivery than building every solution from the ground up. He also said selling an additional copy after the initial product investment has limited incremental cost beyond marketing and sales, which was management's rationale rather than a financial forecast.
Kellton said its client platforms are being designed with AI requirements in mind even where a customer is not yet using AI. The company described this as building AI-ready architecture from the core rather than adding AI later, with the stated aim of avoiding future application redesign or re-engineering. The call did not quantify investment in Phoenix AI or revenue from any IP-led offering.
What is the status of Kellton's rights issue?
Kellton's rights issue was awaiting approval from the National Stock Exchange of India, or NSE, and BSE as of November 16, 2026. Management said it had applied to both exchanges and would work on opening the issue after receiving permissions.
Chintam said Kellton hoped to receive permissions toward the end of November 2026 or the beginning of December 2026. That was management's expectation, not a confirmed timetable from NSE or BSE. The company did not disclose the rights issue size, entitlement ratio, subscription price, record date or intended use of proceeds during the call.
Kellton said its promoters would participate in the rights issue. Management also said shareholders who take up their entitlement can retain the same proportional holding, although the final ownership effects cannot be calculated without the rights ratio, issue price and number of new shares. Those details were not available in the Q2 FY'27 discussion.
Got a follow-up? Ask IRIS
How much dilution could Kellton's plans create?
Kellton said an FCCB would create dilution if converted, but management has not determined terms that would establish its scale. Chintam said the company would announce details after the relevant approvals, while also saying the current share price was not suitable for an FCCB transaction.
The rights issue has a different mechanism from the FCCB because it offers existing holders the opportunity to subscribe in proportion to their holdings. Management said a holder who subscribes to the offered shares should not face proportional dilution from the rights issue. That statement does not establish the effect on holders who do not subscribe, because Kellton did not disclose the entitlement ratio or issue price.
Management linked potential FCCB dilution to its plan to reduce debt and acquire IP, particularly amid AI-related activity. It said products, frameworks and platforms can receive different valuation multiples from services, but did not provide a target product revenue mix, acquisition budget or debt-reduction target. Therefore, the planned capital deployment is directional rather than quantified.
How did Kellton perform before postponing the FCCB?
Kellton reported Q2 FY'27 revenue of Rs 321 crore, about 6.5% higher year on year, with earnings before interest, tax, depreciation and amortisation, or EBITDA, of Rs 39 crore. Profit after tax, or PAT, was Rs 23 crore, while EBITDA margin was 12.1%, PAT margin was 7.2% and earnings per share were 43 paise.
For H1 FY'27, revenue was Rs 637 crore versus Rs 597 crore in the prior-year six-month period, an increase of 6.6%. The H1 comparison shows revenue increased by Rs 40 crore from the corresponding period, while the call provided quarterly profitability figures only for Q2 FY'27.
Kellton also reported six Q2 FY'27 client wins across automotive finance, US healthcare claims processing, Saudi Arabian aviation, automotive logistics, seed engineering and hearing-aid manufacturing. The assignments include an enterprise loan integration platform, an AI-driven claims-management platform, quality-engineering pods, infrastructure support and software, firmware and testing work for Indian research and development operations.
What operating developments support Kellton's IP plan?
Kellton said it won first prize for Niyama, an AI-based regulatory-compliance agent, at a Securities and Exchange Board of India tech sprint held during the Global FinTech Fest. Management said about 525 companies participated, 145 were filtered and 25 reached the final round. It also said the product had generated inbound customer interest, without quantifying contracts or revenue.
The company said it received an Emerging Excellence Award from ADB after onboarding as a technology partner about a year earlier. Management added that ADB had asked whether Kellton could support a new Spain setup, but did not say whether this had become a contract. At another Global FinTech Fest programme for SBI AURA, Kellton placed fourth with an agentic AI concept for personalised banking.
Conclusion
Kellton's funding plans currently have different timing and mechanisms: the FCCB is deferred until management considers market conditions and the share price more suitable, while the rights issue is awaiting NSE and BSE clearance. H1 FY'27 revenue increased Rs 40 crore year on year to Rs 637 crore, and management is linking future external capital to debt retirement, acquisitions and IP development.
The next disclosed milestone is exchange clearance for the rights issue, which management hoped could arrive around the end of November 2026 or the beginning of December 2026. Investors will need the issue price, entitlement ratio and size to assess the rights issue, while any later FCCB would require conversion terms, timing and a quantified use-of-proceeds plan.


